A single-dose regimen of the current killed oral cholera vaccines that have been prequalified by the World Health Organization would make them more attractive for use against endemic and epidemic cholera. We conducted an efficacy trial of a single dose of the killed oral cholera vaccine Shanchol, which is currently given in a two-dose schedule, in an urban area in which cholera is highly endemic.
Technology Partners: MimirTech
Links:
[1] http://admin.indiaenvironmentportal.org.in/feature-article/efficacy-single-dose-inactivated-oral-cholera-vaccine-bangladesh
[2] http://admin.indiaenvironmentportal.org.in/category/author/firdausi-qadri
[3] http://admin.indiaenvironmentportal.org.in/category/author/thomas-f-wierzba
[4] http://admin.indiaenvironmentportal.org.in/category/author/mohammad-ali-et-al
[5] http://admin.indiaenvironmentportal.org.in/category/journal/new-england-journal-medicine
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/cholera
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/bangladesh
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/south-asia
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/vaccination
[10] http://admin.indiaenvironmentportal.org.in/category/thesaurus/child-health
[11] http://admin.indiaenvironmentportal.org.in/category/thesaurus/waterborne-diseases
